Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Plant Bioscience Limited currently has 3 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are handled by 3 distinct examiners across 2 distinct art units. This distribution shows that each pending matter is assigned to a different examiner, while the technology is split between two specialized units. The use of 2 distinct art units indicates that the company's biotechnology innovations are categorized into at least two different examination specialties.
Karen M Redden is the busiest examiner for this portfolio, managing 1 pending office action. With 3 pending office actions in total, the prosecution workload is spread evenly across the 3 distinct examiners involved. This decentralized structure means that the company is receiving feedback from 3 distinct examiners. This variety of examiner perspectives can lead to different prosecution experiences across the portfolio, as each of the 3 distinct examiners may have unique approaches to the examination process. Practitioners should be prepared to manage these matters across the 2 distinct art units.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (33%) |
| Double-patenting + other | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| REDDEN, KAREN M | 1 | 88.4% | -21.5% |
| STEPHENS, REBECCA JOHANNA | 1 | 67.3% | +29.3% |
| MOAZZAMI, NAGHMEH NINA | 1 | 72.0% | +49.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19100249 | METHODS OF ALTERING THE STARCH GRANULE PROFILE IN PLANTS | REDDEN, KAREN M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18958360 | METHODS FOR ALTERING STARCH GRANULE PROFILE | STEPHENS, REBECCA JOHANNA | — |
| 18849851 | BIOSYNTHESIS | MOAZZAMI, NAGHMEH NINA | — |
| Art Unit | Apps |
|---|---|
| 1661 | 1 |
| 1663 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19100249 | METHODS OF ALTERING THE STARCH GRANULE PROFILE IN PLANTS | REDDEN, KAREN M | 1661 | §102§103 | Non-Final OA | — | Pending | Jan 31, 2025 |
| 18958360 | METHODS FOR ALTERING STARCH GRANULE PROFILE | STEPHENS, REBECCA JOHANNA | 1663 | §102§112DPOther | Non-Final OA | — | Pending | Nov 25, 2024 |
| 18849851 | BIOSYNTHESIS | MOAZZAMI, NAGHMEH NINA | — | §112Other | Non-Final OA | — | Pending | Sep 23, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial